Organism name | Alternaria brassicae |
---|---|
Genus | Alternaria |
Family | Dothideomycetes |
Kingdom | Fungi |
Linked NCBI taxonomy name | Alternaria brassicae |
---|---|
Linked NCBI taxonomy ID | 29911 |
Linked level | species |
Family in NCBI taxonomy | Pleosporaceae |
---|---|
ID | 28556 |
Kingdom (Superkingdom) in NCBI taxonomy | Fungi |
---|---|
ID | 4751 |
Plant class | |
---|---|
ID |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00037274
![]() |
Homodestruxin B
|
C086296
|
No. 892 |
![]() |
||||
C00037040
![]() |
Destruxin B
|
CHEMBL444243
|
C040424
|
19 / 3 | No. 892 |
![]() |
||
C00037037
![]() |
Destruxin DMDB
/ Desmethyldestruxin B |
No. 892 |
![]() |
|||||
C00000134
![]() |
(s)-(+)-Abscisic acid
/ 2,4-Pentadienoic acid |
CHEMBL288040
CHEMBL379808 CHEMBL1318134 CHEMBL1469719 CHEMBL1741460 CHEMBL1965138 |
D000040
|
10 / 9 / 10 | No. 1435 | No. 38 |
![]() |
|
C00020278
![]() |
Isoalbrassitriol
|
No. 2386 |
![]() |
|||||
C00020280
![]() |
Albrassitriol
|
C100709
|
No. 2802 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000134 | 1 / 0 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00000134 | 3 / 2 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000134 | 0 / 1 |
P10145 | Interleukin-8 | Secreted protein | C00000134 | 0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000134 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00000134 | 1 / 1 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000134 | 1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000134 | 0 / 1 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00000134 | 0 / 0 |
P10275 | Androgen receptor | NR3C4 | C00000134 | 3 / 4 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
308 | ANXA5, ANX5, ENX2, PP4, RPRGL3 | annexin A5 |
C00037040
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00037040
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00037040
|
598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 |
C00037040
|
332 | BIRC5, API4, EPR-1 | baculoviral IAP repeat containing 5 |
C00037040
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00037040
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00037040
|
1147 | CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16 | conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) |
C00037040
|
1499 | CTNNB1, CTNNB, MRD19, armadillo | catenin (cadherin-associated protein), beta 1, 88kDa |
C00037040
|
2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00037040
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00037040
|
4313 | MMP2, CLG4, CLG4A, MMP-II, MONA, TBE-1 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) |
C00037040
|
4318 | MMP9, CLG4B, GELB, MANDP2, MMP-9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) |
C00037040
|
4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00037040
|
4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00037040
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00037040
|
5175 | PECAM1, CD31, CD31/EndoCAM, GPIIA', PECA1, PECAM-1, endoCAM | platelet/endothelial cell adhesion molecule 1 |
C00037040
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00037040
|
6925 | TCF4, E2-2, ITF-2, ITF2, PTHS, SEF-2, SEF2, SEF2-1, SEF2-1A, SEF2-1B, TCF-4, bHLHb19 | transcription factor 4 |
C00037040
|
OMIM | preferred title | UniProt |
---|---|---|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#615363 | Estrogen resistance; estrr |
P03372
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
KEGG | name | UniProt |
---|---|---|
H00026 | Endometrial Cancer |
P03372
(marker)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|